{"id":8957,"date":"2023-01-11T12:52:23","date_gmt":"2023-01-11T12:52:23","guid":{"rendered":"https:\/\/dev-espa.summerize.io\/recovery-fund-investments-of-e520-million-in-the-pharmaceutical-sector\/"},"modified":"2023-08-27T06:05:46","modified_gmt":"2023-08-27T06:05:46","slug":"recovery-fund-investments-of-e520-million-in-the-pharmaceutical-sector","status":"publish","type":"post","link":"https:\/\/espa.io\/en\/recovery-fund-investments-of-e520-million-in-the-pharmaceutical-sector\/","title":{"rendered":"Recovery Fund: Investments of \u20ac520 million in the pharmaceutical sector"},"content":{"rendered":"\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/espa.io\/wp-content\/uploads\/2023\/08\/tameio-anakampsis-520-ekat-ependisi-ston-klado-tou-farmakou-1024x440.jpg\" alt=\"\"\/><\/figure>\n\n<p><strong>The investment planning of the domestic <a href=\"https:\/\/espa.io\/en\/c\/health-medication-social-welfare\/\" target=\"_blank\" rel=\"noreferrer noopener\">pharmaceutical industry<\/a> is in full swing<\/strong>, after the <strong>Approval of 53 investments amounting to 519.28 million euros<\/strong>  in the framework of the action <strong>&#8220;Reform of the clawback system &amp; its offsetting with research and investment expenditure&#8221;,<\/strong> of the <strong>\n  <a href=\"https:\/\/greece20.gov.gr\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">National Recovery and Resilience Plan &#8220;Greece 2.0&#8221;<\/a>\n<\/strong>.<\/p>\n\n<p><strong>These 53 projects fulfil all the conditions for participation<\/strong> and the eligibility conditions. <strong>85% of them are implemented by Greek companies.<\/strong> The above projects are part of the plan of the Greek pharmaceutical industry. This plan provides for <strong>investments totalling \u20ac1.2 billion euro over four years<\/strong>. This is what the <strong><a href=\"https:\/\/www.pef.gr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Panhellenic Association of the Pharmaceutical Industry<\/a><\/strong> (PEF) said in a statement.<\/p>\n\n<p>&#8220;These investments have a <strong>unique multiplier effect on the economy,<\/strong> through the creation of added value that remains and is reinvested in the country. In addition, these investments <strong>reduce Greece&#8217;s trade deficit<\/strong>. This is because the d<strong>omestic production of medicine ensures that the needs are met<\/strong>. At the same time, <strong>employment is strengthened with permanent, skilled and well-paid new jobs&#8221;<\/strong>, emphasizes (ECEC).<\/p>\n\n<p>He notes that with the completion of the investment program, <strong>Greece will be able to become a European &#8220;hub&#8221; of production, research and innovation<\/strong>. At the same time, <strong>the phase-out of drug imports from third countries,<\/strong> such as China and Asia, will be completed. At the same time<strong>, domestic production will be further strengthened.<\/strong> In addition, <strong>exports abroad will increase<\/strong>, thus contributing to the reduction of the trade deficit.<\/p>\n\n<h2 class=\"wp-block-heading\" id=\"h-&#x3B8;&#x3B5;&#x3CC;&#x3B4;&#x3C9;&#x3C1;&#x3BF;&#x3C2;-&#x3C4;&#x3C1;&#x3CD;&#x3C6;&#x3C9;&#x3BD;-&#x3C0;&#x3C1;&#x3CC;&#x3B5;&#x3B4;&#x3C1;&#x3BF;&#x3C2;-&#x3C4;&#x3B7;&#x3C2;-&#x3C0;&#x3B1;&#x3BD;&#x3B5;&#x3BB;&#x3BB;&#x3AE;&#x3BD;&#x3B9;&#x3B1;&#x3C2;-&#x3AD;&#x3BD;&#x3C9;&#x3C3;&#x3B7;&#x3C2;-&#x3C4;&#x3B7;&#x3C2;-&#x3B2;&#x3B9;&#x3BF;&#x3BC;&#x3B7;&#x3C7;&#x3B1;&#x3BD;&#x3AF;&#x3B1;&#x3C2;-&#x3C4;&#x3BF;&#x3C5;-&#x3C6;&#x3B1;&#x3C1;&#x3BC;&#x3AC;&#x3BA;&#x3BF;&#x3C5;\"><strong>Theodoros Tryfon, president of the Panhellenic Association of the pharmaceutical industry<\/strong><\/h2>\n\n<p>\u00ab<strong>The Greek pharmaceutical industry actively participates in the recovery effort of the national economy<\/strong>. With the assistance of the three co-competent ministries and in the context of offsetting the clawback with the productive investments of the sector, <strong>investments that have multiplier benefits for society are implemented<\/strong>. Especially <strong>shield the health and pharmaceutical care system<\/strong>, ensuring market adequacy and patients&#8217; access to all necessary treatment; <strong>reducing dependence on imports<\/strong>, while at the same time leading to the <strong>Promotion of our country as a hub for the research and production of medicines<\/strong> in the wider region of SE Europe&#8221;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The investment planning of the domestic pharmaceutical industry is in full swing, after the Approval of 53 investments amounting to 519.28 million euros in the framework of the action &#8220;Reform of the clawback system &amp; its offsetting with research and investment expenditure&#8221;, of the National Recovery and Resilience Plan &#8220;Greece 2.0&#8221; . These 53 projects [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2246,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,109,1075],"tags":[2605,2606],"aid_type_posts":[2081],"activity_posts":[2016],"investment_region_posts":[2022,2018,2053,2025,2026,2023,2028,2024,2019,2030,2027,2029,2020,2021],"business_type_posts":[2032,2031],"funding_type_posts":[2039],"business_size_posts":[2033,2034,2035,2036],"category_of_beneficiary_posts":[2037,2043,2047],"class_list":["post-8957","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","category-mi-katigoriopoiimeno","category-ugeia-farmaka-koinoniki-merimna-epidotisi","tag-pharmaceutical-industry","tag-social-care","aid_type_posts-2081","activity_posts-health-medicines-social-care","investment_region_posts-all-of-greece","investment_region_posts-attica-en","investment_region_posts-central-greece","investment_region_posts-central-macedonia","investment_region_posts-crete","investment_region_posts-eastern-macedonia-and-thrace","investment_region_posts-epirus","investment_region_posts-ionian-islands","investment_region_posts-north-aegean","investment_region_posts-peloponnese","investment_region_posts-southern-aegean-sea","investment_region_posts-thessaly","investment_region_posts-west-greece","investment_region_posts-western-macedonia","business_type_posts-existing-businesses","business_type_posts-new-businesses","funding_type_posts-subsidy","business_size_posts-medium","business_size_posts-small","business_size_posts-2035","business_size_posts-2036","category_of_beneficiary_posts-businesses","category_of_beneficiary_posts-individuals","category_of_beneficiary_posts-public-sector"],"_links":{"self":[{"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/posts\/8957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/comments?post=8957"}],"version-history":[{"count":2,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/posts\/8957\/revisions"}],"predecessor-version":[{"id":29890,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/posts\/8957\/revisions\/29890"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/media\/2246"}],"wp:attachment":[{"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/media?parent=8957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/categories?post=8957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/tags?post=8957"},{"taxonomy":"aid_type_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/aid_type_posts?post=8957"},{"taxonomy":"activity_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/activity_posts?post=8957"},{"taxonomy":"investment_region_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/investment_region_posts?post=8957"},{"taxonomy":"business_type_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/business_type_posts?post=8957"},{"taxonomy":"funding_type_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/funding_type_posts?post=8957"},{"taxonomy":"business_size_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/business_size_posts?post=8957"},{"taxonomy":"category_of_beneficiary_posts","embeddable":true,"href":"https:\/\/espa.io\/en\/wp-json\/wp\/v2\/category_of_beneficiary_posts?post=8957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}